Sweden· SE-20250227000022
Ojemda 25 mg/ml Pulver till oral suspension
A medicinal product containing tovorafenib, registered in Sweden by Ipsen Pharma.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tovorafenib
- Manufacturer
- Ipsen Pharma
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20250227000022
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tovorafenib in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOjemda 25 mg/mlIpsen Pharma
- SwitzerlandOjemda 25 mg/ml, Pulver zur Herstellung einer Suspension zum EinnehmenIPSEN Pharma Schweiz GmbH
- CzechiaOJEMDAIPSEN PHARMA S.A.S., Paříž
- FinlandOjemdaIpsen Pharma
- IcelandOjemdaIpsen Pharma
- NetherlandsOjemda 25 mg/ml poeder voor suspensie voor oraal gebruikIpsen Pharma
- PolandOjemdaIpsen Pharma
- United StatesOJEMDADay One Biopharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ojemda
- Liechtenstein · Ojemda
- Norway · Ojemda
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9b977a7c-cdb3-4c8d-af53-c81a07a14ad3 GET /v1/drugs/9b977a7c-cdb3-4c8d-af53-c81a07a14ad3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"Dispensbeslut",
"EPAR",
"EMA"
],
"se_npl_id": "20250227000022",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20250227000022",
"product_doc_link": "https://docetp.mpa.se/LMF/Ojemda%2C%20flaska%2C%201st%2C%20sammanfattning%20av%20beslut%2C%20giltigt%20fr.o.m.%202026-07-03%20t.o.m.%202028-08-01_09001bee851a4e98.pdf"
}See everything about tovorafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.